Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “New-onset Type 1 Diabetes Mellitus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05031429
What this trial is testing

Time Limited Eating in Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Children's Hospital Los Angeles 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT04335656
What this trial is testing

Reducing Innate Inflammation in New Onset Type 1 Diabetes

Who this might be right for
Type 1 Diabetestype1diabetesType 1 Diabetes Mellitus
Medical College of Wisconsin 60
Testing effectiveness (Phase 2)Study completedNCT04774224
What this trial is testing

Baricitinib in New-onset Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
St Vincent's Institute of Medical Research 91
Testing effectiveness (Phase 2)Study completedNCT02000817
What this trial is testing

Investigation of Otelixizumab in New-Onset, Autoimmune Type 1 Diabetes Mellitus Patients

Who this might be right for
Diabetes Mellitus, Type 1
GlaxoSmithKline 30
Early research (Phase 1)Ended earlyNCT01183468
What this trial is testing

A Research Trial of Aralast in New Onset Diabetes (RETAIN)

Who this might be right for
Diabetes Mellitus, Type 1
National Institute of Allergy and Infectious Diseases (NIAID) 17
Testing effectiveness (Phase 2)Ended earlyNCT06025110
What this trial is testing

TCD601 (Siplizumab) in New Onset Type 1 Diabetes Patients

Who this might be right for
Diabetes Mellitus, Type 1
ITB-Med LLC 9
Early research (Phase 1)Study completedNCT00525889
What this trial is testing

Proleukin and Rapamune in Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
National Institute of Allergy and Infectious Diseases (NIAID) 9
Large-scale testing (Phase 3)Ended earlyNCT05018585
What this trial is testing

A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes Mellitus
Diamyd Medical AB 321
Large-scale testing (Phase 3)Study completedNCT00711503
What this trial is testing

Anti-Interleukin-1 in Diabetes Action

Who this might be right for
Type 1 Diabetes
Steno Diabetes Center Copenhagen 69
Testing effectiveness (Phase 2)Study completedNCT02293837
What this trial is testing

Tocilizumab (TCZ) in New-onset Type 1 Diabetes

Who this might be right for
Type 1 Diabetes MellitusNew-onset Type 1 Diabetes MellitusT1DM+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 136
Testing effectiveness (Phase 2)Study completedNCT02814838
What this trial is testing

A Phase 2, Multicentre, Randomized, Double-blind, Placebo-controlled Study in Patients With New-onset Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Insulin-Dependent
Dompé Farmaceutici S.p.A 76
Testing effectiveness (Phase 2)Study completedNCT03182426
What this trial is testing

Stem Cell Mobilization (Plerixafor) and Immunologic Reset in Type 1 Diabetes (T1DM)

Who this might be right for
Diabetes Mellitus, Type 1
University of Alberta 22
Testing effectiveness (Phase 2)Study completedNCT02284009
What this trial is testing

Albiglutide Versus Placebo in Insulin-treated Subjects With New-onset Type 1 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 1
GlaxoSmithKline 67
Not applicableStudy completedNCT06177691
What this trial is testing

Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension Study

Who this might be right for
Type1 Diabetes
Jaeb Center for Health Research 77
Testing effectiveness (Phase 2)Ended earlyNCT02044848
What this trial is testing

Study of Secukinumab in Patients With Newly-diagnosed Type 1 Diabetes Mellitus

Who this might be right for
Type 1 Diabetes Mellitus
Novartis Pharmaceuticals 5
Testing effectiveness (Phase 2)Looking for participantsNCT07142252
What this trial is testing

Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

Who this might be right for
Type 1 Diabetes Mellitus
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 66
Not applicableUnknownNCT02871089
What this trial is testing

Closed Loop From Onset in Type 1 Diabetes

Who this might be right for
Diabetes MellitusType 1 Diabetes
University of Cambridge 96
Testing effectiveness (Phase 2)Study completedNCT02215200
What this trial is testing

ATG-GCSF in New Onset Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 89
Large-scale testing (Phase 3)Looking for participantsNCT07222332
What this trial is testing

Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)

Who this might be right for
Diabetes Mellitus, Type 1
Eli Lilly and Company 300
Not applicableUnknownNCT01781884
What this trial is testing

Effects Of Gamma Aminobutyric Acid On The Progression Of New Onset Juvenile Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Huashan Hospital 60
Next Page